reduce basal insulin when starting glp-1 receptor agonist Agonists as Treatments for Type 2 Diabetes Mechanisms of action of GLP-1RA.
Description
In addition, the long-term effects of GLP-1RA therapy on HF need further investigation
Tirzepatide is a dual-action medication that mimics both GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide)
A small human proof-of-concept trial reported that semaglutide reduced vastus lateralis cross-sectional area but did not reduce knee-extension strength or grip strength over 12 weeks
The authors declare the following competing financial interest(s): A.S.K., A.M.M., M.C.G., J.M.D., C.B., C.L., S.W.B., D.L., P.M.L., D.R.D., J.M.C., J.-P.F., Y.L., A.R.S., D.A.T., D.W.P., S.H., M.S.L., and D.A.G
Whether the higher reporting rate reflects a genuine biological susceptibility or simply higher usage remains unclear
Dublin, Jan
